Laura Bush, DMSc, PA-C, DFAAPA

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Boehringer-Ingelheim
    Topic:
    rare diseases
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    06/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Johnson & Johnson
    Topic:
    Psoriasis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Takeda
    Topic:
    psoriasis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    01/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    UCB
    Topic:
    HS
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Leo
    Topic:
    Dermatitis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    11/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Amgen
    Topic:
    Psoriasis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    11/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Loreal
    Topic:
    OTC
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Dermavant
    Topic:
    Psoriasis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Janssen
    Topic:
    Psoriasis
    Date added:
    06/18/2026
    Date updated:
    06/18/2026
    Relationship end date:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    Vertex Pharmaceuticals
    Date added:
    06/18/2026
    Date updated:
    06/18/2026

Pages

Return to 2026 Science of Skin Summit